TWST

Twist Bioscience Corporation NMS · TWST

$87.45 -6.40 (-6.82%)

Neutral · -0.38σ Grade C

+ Compare Open in Sniper

Mkt cap $5.4B

P/E —

Day $87.32 – $96.76

52wk $39.66 – $105.47

Avg vol 1.8M

Beta 2.12

Div yld —

Next earnings 2026-08-03

Quick read

Plain English

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products.

TWST last traded at $87.45, down 6.8% on the day; that's in the upper part of its 52-week range ($39.66–$105.47). Right now it's trading close to its recent average, with no strong stretch in either direction.

The next scheduled earnings report (2026-08-03) is the biggest known catalyst on the calendar, and day to day, watch whether it holds above or slips below its recent average.

A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.

Today's read

Grading desk →

KC1 upper, -0.45 ATR from EMA21 — bearish engulfing

Long —

score 16 · tech 16 / 80 · support 0 / 20

above KC1 lower, -0.45 ATR from EMA21 · no notable pattern

· Aligned with breakout up (strong tailwind)

How this grade was earned

total 16 pts

Cycle position 6

Market fit 10

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

Short C

score 27 · tech 27 / 80 · support 0 / 20

KC1 upper, -0.45 ATR from EMA21 · bearish engulfing

· KC1 upper stretch — light pop
· Bearish engulfing — body fully covers prior green bar
· Counter-trend short in breakout up

How this grade was earned

total 27 pts

Cycle position 14

Candle signal 13

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

The model's verdict is “Unknown” and accounting quality screens as Weak. Model estimates only — do your own due diligence.

Fair-value range

$18.14 – $18.14

Verdict

Unknown

Accounting quality Weak

✓ More cash than debt
✓ Quick ratio 2.50 (antifragile)
✓ Current ratio 3.64 (antifragile)
✓ Debt/equity 0.36 (antifragile)

⚠ Negative retained earnings
⚠ Receivables growing faster than revenue
⚠ Stock comp 17% of revenue (heavy dilution)

Key statistics

All statistics →

TWST is a $5.4 billion company, it moves harder than the market (beta 2.1).

Mkt cap $5.4B

P/E ttm —

Fwd P/E -114.6

Beta 2.12

Day range $87.32 – $96.76

52w range $39.66 – $105.47

Avg vol 1.8M

RSI(2) 17.9

ROE -18.2%

Net mgn -19.8%

FCF mgn -14.3%

Debt/Eq 0.24

Div yld —

Sector Healthcare

Industry Diagnostics & Research

Next earn 2026-08-03

52-week range · today's price

$39.66$105.47

More on TWST

Options idea

See more →

CALL $92 2026-08-21

$9.32

PUT $90 2026-08-21

$8.78

Earnings

See more →

Last reported: 2026-05-04
EPS (act / est): -0.60 / -0.53
Surprise: -12.6%
Next report: 2026-08-03

About

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as ac…